Capitalizing Next Gen Sequencing to make cancer genome testing accessible, affordable
This blog will explore how NGS is deployed at Karkinos Healthcare to transform the cancer diagnostic landscape in the country and beyond.
A technology-led, purpose driven oncology platform, enabling discovery through delivery of care
HomeDigital Oncology
This blog will explore how NGS is deployed at Karkinos Healthcare to transform the cancer diagnostic landscape in the country and beyond.
Recently, on June 20th, at CIMS (Career Institute of Medical Sciences), located in Bhopal, Team Karkinos completed processing 100 fractions (100 patients treated) in a single day. This is considered to be a significant achievement.
This article brings to fore the expertise of Karkinos Healthcare in providing Decentralised Clinical Trials (DCTs) services in bringing about novel approaches to cancer treatment. To know more about the compelling reasons for the emergence of DCTs in India and what makes the country a hotbed for global pharmaceutical companies to conduct DCTs, please subscribe to the full article at https://karkinos.in/clinicaltrials/.
This blog explains how a VTB can be leveraged to bring out the best treatment outcomes by doctors and how it benefit the patients at large.
Bioinformatics is a requisite in the molecular understanding of cancer causing genes and Karkinos Healthcare is keen on delivering personalized medicine and personal care in cancer treatment by leveraging bioinformatics.
Karkinos Healthcare was among the additional 12 health service applications that recently completed their integration in the ABDM Sandbox Environment. After a successful demonstration, Karkinos’ Application Suite was approved to be added to the ABDM Partners Ecosystem.
While participatory healthcare is very important and is gaining momentum, patients have to be active players in their own health journey and hence in this context PROs become absolutely important.